These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34126417)

  • 21. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
    BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas.
    Balasubramanian A; Subramaniam R; Narayanan V; Annamalai T; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1615-9. PubMed ID: 25743841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics.
    Allameh A; Moazeni-Roodi A; Harirchi I; Ravanshad M; Motiee-Langroudi M; Garajei A; Hamidavi A; Mesbah-Namin SA
    Pathol Oncol Res; 2019 Oct; 25(4):1535-1543. PubMed ID: 30511108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and epigenetic regulation of DACT1 and DACT2 in oral squamous cell carcinoma.
    Schussel JL; Kalinke LP; Sassi LM; de Oliveira BV; Pedruzzi PA; Olandoski M; Alvares LE; Garlet GP; Trevilatto PC
    Cancer Biomark; 2015; 15(1):11-7. PubMed ID: 25524937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ORAOV1 is amplified in oral squamous cell carcinoma.
    Xavier FC; Rodini CO; Paiva KB; Destro MF; Severino P; Moyses RA; ; Tajara EH; Nunes FD
    J Oral Pathol Med; 2012 Jan; 41(1):54-60. PubMed ID: 21623924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of methylation markers for diagnosis of oral cavity cancer.
    Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
    Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient.
    Sun Y; Yang J; Cai H; Liu J; Liu Y; Luo J; Zhou H
    J Oral Pathol Med; 2022 Aug; 51(7):611-619. PubMed ID: 35708285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of potential CpG sites for oral squamous cell carcinoma diagnosis via integrated analysis of DNA methylation and gene expression.
    Chen L; Wang D
    World J Surg Oncol; 2021 Jan; 19(1):16. PubMed ID: 33468155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
    Reddy VR; Annamalai T; Narayanan V; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.
    Zhou C; Li J; Li Q; Liu H; Ye D; Wu Z; Shen Z; Deng H
    J Clin Lab Anal; 2019 Jun; 33(5):e22873. PubMed ID: 30843252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylated PAX1 and ZNF582 genes in the tissue sample are associated with aggressive progression of oral squamous cell carcinoma.
    Sun R; Juan YC; Su YF; Zhang WB; Yu Y; Yang HY; Yu GY; Peng X
    J Oral Pathol Med; 2020 Sep; 49(8):751-760. PubMed ID: 32428271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.
    Uchida K; Veeramachaneni R; Huey B; Bhattacharya A; Schmidt BL; Albertson DG
    BMC Cancer; 2014 May; 14():353. PubMed ID: 24886209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant promoter methylation of T-cadherin in sera is associated with a poor prognosis in oral squamous cell carcinoma.
    Wang Q; Chen Y; Chen Y; Jiang J; Song X; Zhang L; He Q; Ye B; Wu L; Wu R; Lai Q; Wang D; Zhao Y
    Neoplasma; 2021 May; 68(3):528-534. PubMed ID: 33567853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma.
    Khor GH; Froemming GR; Zain RB; Abraham TM; Lin TK
    Asian Pac J Cancer Prev; 2016; 17(1):219-23. PubMed ID: 26838213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter methylation of MGMT in oral carcinoma: A population-based study and meta-analysis.
    Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
    Arch Oral Biol; 2017 Aug; 80():197-208. PubMed ID: 28458179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
    Yue ZW; Liu JZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
    [No Abstract]   [Full Text] [Related]  

  • 39. Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population.
    Goel H; Mathur R; Syeda S; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):977-982. PubMed ID: 33773564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced ribosomal RNA expression and unchanged ribosomal DNA promoter methylation in oral squamous cell carcinoma.
    Ha S; Zhou H; Gautam M; Song Y; Wang C
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00783. PubMed ID: 31169368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.